I attended the MedTech UCL AI in Medicine Conference: a bespoke, one-day conference bringing together some of the greatest minds in digital health. With speakers from Google DeepMind, BenevolentAI, NHS X and others. The day consisted of talks, discussions on the greater implications of AI in healthcare, exciting workshops.
BenevolentAI integrates AI technologies at every step of the drug discovery process from early discovery to late stage clinical development.It has a platform of computational and experimental technologies and processes using vast quantities of mined and inferred biomedical data
AI uses already generated medical data for research into areas like biomedical sciences. AI research also explains the difference in the prevalence of certain diseases amongst different races for example diabetes affects Asians more than Africans.
BenevolentAI collaborates with international organisations such as the African genome variation project.
Genetic studies of human diseases are more challenging to perform in sub-saharan Africa because genetic diversity is greater than in other populations.This pilot will increase our understanding of African genome variation and enable the design of large scale genetic association studies in the region.
The African genome variation project aims to collect essential information about the structure of African genmes to provide basic framework for genetic disease studies in Africa.
Clinical trials are relatively absent in most parts of Africa and there is an opportunity to bridge the gap ad provide data for AI needs
